Salem Investment Counselors’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $214K | Sell |
13,446
-3,250
| -19% | -$50.4K | 0.01% | 400 |
|
|
2026
Q1 | $226K | Sell |
16,696
-1,248
| -7% | -$17.5K | 0.01% | 364 |
|
|
2025
Q4 | $223K | Sell |
17,944
-7,479
| -29% | -$80.7K | 0.01% | 365 |
|
|
2025
Q3 | $252K | Sell |
25,423
-10,988
| -30% | -$107K | 0.01% | 350 |
|
|
2025
Q2 | $325K | Sell |
36,411
-3,911
| -10% | -$33.1K | 0.01% | 322 |
|
|
2025
Q1 | $351K | Sell |
40,322
-1,000
| -2% | -$10.5K | 0.01% | 293 |
|
|
2024
Q4 | $514K | Sell |
41,322
-3,090
| -7% | -$38K | 0.02% | 265 |
|
|
2024
Q3 | $516K | Sell |
44,412
-4,310
| -9% | -$49.7K | 0.02% | 270 |
|
|
2024
Q2 | $518K | Sell |
48,722
-10,533
| -18% | -$116K | 0.02% | 258 |
|
|
2024
Q1 | $708K | Sell |
59,255
-11,912
| -17% | -$143K | 0.02% | 226 |
|
|
2023
Q4 | $771K | Sell |
71,167
-39,348
| -36% | -$377K | 0.03% | 208 |
|
|
2023
Q3 | $1.09M | Sell |
110,515
-2,064
| -2% | -$21.5K | 0.04% | 169 |
|
|
2023
Q2 | $1.12M | Sell |
112,579
-7,284
| -6% | -$69.6K | 0.04% | 163 |
|
|
2023
Q1 | $1.15M | Sell |
119,863
-1,124
| -0.9% | -$12.5K | 0.05% | 164 |
|
|
2022
Q4 | $1.35M | Sell |
120,987
-51,488
| -30% | -$538K | 0.06% | 147 |
|
|
2022
Q3 | $1.47M | Buy |
172,475
+20,816
| +14% | +$205K | 0.07% | 141 |
|
|
2022
Q2 | $1.59M | Buy |
151,659
+599
| +0.4% | +$6.57K | 0.07% | 144 |
|
|
2022
Q1 | $1.64M | Buy |
151,060
+24,508
| +19% | +$323K | 0.06% | 151 |
|
|
2021
Q4 | $1.71M | Buy |
126,552
+124,880
| +7,469% | +$1.67M | 0.06% | 148 |
|
|
2021
Q3 | $23K | Sell |
1,672
-65
| -4% | -$922 | ﹤0.01% | 620 |
|
|
2021
Q2 | $25K | Sell |
1,737
-163
| -9% | -$2.36K | ﹤0.01% | 584 |
|
|
2021
Q1 | $27K | Sell |
1,900
-37,009
| -95% | -$603K | ﹤0.01% | 552 |
|
|
2020
Q4 | $729K | Buy |
38,909
+38,709
| +19,355% | +$631K | 0.05% | 171 |
|
|
2020
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 642 |
|
|
2020
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 634 |
|
|
2020
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 613 |
|
|
2019
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 630 |
|
|
2019
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 585 |
|
|
2019
Q2 | $4K | Buy |
+200
| New | +$4.42K | ﹤0.01% | 609 |
|
|
2018
Q3 | – | Sell |
-1,000
| Closed | -$36K | – | 524 |
|
|
2018
Q2 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 328 |
|
|
2018
Q1 | $40K | Buy |
1,000
+200
| +25% | +$8.53K | ﹤0.01% | 316 |
|
|
2017
Q4 | $34K | Hold |
800
| – | – | ﹤0.01% | 353 |
|
|
2017
Q3 | $26K | Sell |
800
-20
| -2% | -$679 | ﹤0.01% | 370 |
|
|
2017
Q2 | $32K | Buy |
820
+20
| +3% | +$767 | ﹤0.01% | 361 |
|
|
2017
Q1 | $31K | Sell |
800
-33
| -4% | -$1.33K | ﹤0.01% | 425 |
|
|
2016
Q4 | $32K | Buy |
833
+33
| +4% | +$1.23K | ﹤0.01% | 398 |
|
|
2016
Q3 | $305 | Sell |
800
-30,075
| -97% | -$1.34M | ﹤0.01% | 353 |
|
|
2016
Q2 | $1.33M | Buy |
+30,875
| New | +$1.37M | 0.16% | 117 |
|
Other funds holding VTRS
ACM
WCM
AL
TIM
QAM
LCS
Salem Investment Counselors's VTRS Position: Q2 2026 in Review
Salem Investment Counselors reduced its Viatris (VTRS) stake by 19% in Q2 2026, selling an estimated $50.4K and leaving 13,446 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #400.
Salem Investment Counselors first reported a position in VTRS in Q2 2016 and has held it in 38 quarters since. The position peaked at $1.71M in Q4 2021. 411 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- Salem Investment Counselors held 13,446 shares of Viatris worth $214K as of Q2 2026.
- Salem Investment Counselors sold 3,250 Viatris shares in Q2 2026, an estimated $50.4K.
- Viatris made up 0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #400 holding.
- Salem Investment Counselors first reported a position in Viatris in Q2 2016 and has held it in 38 quarters since.
- Salem Investment Counselors's Viatris position peaked at $1.71M in Q4 2021.
- 411 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.